GlassScriptPhysician profile
Shari Strier
NPI 1881699627
$1,832.02
in general payments reported to CMS, 2019-2025
21 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $170 · 2021: $81.86 · 2022: $168 · 2023: $321 · 2024: $368 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232 · Entertainment: $20.44 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.01 |
| Entertainment | $20.44 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $270.50 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $189.88 | 2020-2025 | Cequa |
| Oyster Point Pharma, INC. | $170.95 | 2022-2024 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $166.31 | 2019-2021 | |
| Dompe US, INC. | $154.06 | 2019-2025 | Oxervate |
| Alcon Vision LLC | $122.26 | 2022-2025 | Rocklatan, Tryptyr, Hydrus Microstent |
| Sight Sciences, INC. | $110.54 | 2024-2025 | Omni Surgical System, Tearcare System |
| Abbvie INC. | $107.03 | 2022-2025 | Lumigan, Alphagan P, Durysta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.81 | 2020-2021 | |
| Harrow Eye, LLC | $73.09 | 2024-2025 | Vevye |
| Kala Pharmaceuticals, INC. | $70.36 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $63.33 | 2023-2025 | Infuse, Vyzulta, Miebo |
| Lkc Technologies, INC. | $45.45 | 2024 | |
| Coopervision INC. | $41.74 | 2019-2024 | Myday Contact Lens |
| Thea Pharma INC. | $29.54 | 2024-2025 | Iyuzeh |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $25.31 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Glaukos Corporation | $24.44 | 2023 | |
| Novartis Pharmaceuticals Corporation | $21.69 | 2023 | |
| Tearlab Corp | $21.05 | 2019 | |
| Optos, INC. | $20.44 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Strier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.